Insmed
INSM
#542
Rank
โ‚ฌ37.36 B
Marketcap
175,22ย โ‚ฌ
Share price
-0.51%
Change (1 day)
146.22%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ1.21 Billion

According to Insmed's latest financial reports the company's total liabilities are โ‚ฌ1.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ1.67 B11.22%
2023-12-31โ‚ฌ1.50 B2.8%
2022-12-31โ‚ฌ1.46 B98.79%
2021-12-31โ‚ฌ0.73 B73.9%
2020-12-31โ‚ฌ0.42 B-1.41%
2019-12-31โ‚ฌ0.42 B23.85%
2018-12-31โ‚ฌ0.34 B311.57%
2017-12-31โ‚ฌ84.16 M6.06%
2016-12-31โ‚ฌ79.35 M93.43%
2015-12-31โ‚ฌ41.02 M11.81%
2014-12-31โ‚ฌ36.69 M52.75%
2013-12-31โ‚ฌ24.02 M-2.77%
2012-12-31โ‚ฌ24.7 M476.41%
2011-12-31โ‚ฌ4.28 M66.6%
2010-12-31โ‚ฌ2.57 M32.54%
2009-12-31โ‚ฌ1.94 M-64.2%
2008-12-31โ‚ฌ5.42 M-1.18%
2007-12-31โ‚ฌ5.48 M-49.96%
2006-12-31โ‚ฌ10.96 M5.25%
2005-12-31โ‚ฌ10.41 M144.67%
2004-12-31โ‚ฌ4.25 M49.24%
2003-12-31โ‚ฌ2.85 M-38.63%
2002-12-31โ‚ฌ4.64 M-65.53%
2001-12-31โ‚ฌ13.48 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ1.86 B 53.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ53.71 B 4,319.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ31.84 B 2,519.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ1.03 B-14.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.46 B-61.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ6.47 B 433.05%๐Ÿ‡บ๐Ÿ‡ธ USA